Teva Pharmaceutical Launches First Generic Formulation of Gilead's Blockbuster Antiretroviral Truvada
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Pharmaceuticals - Generic and Specialty Pharmaceuticals | Start-Up Nation Finder
Pfizer Wins $2.15B Patent Suit with Teva, Sun Pharma | Fox Business
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022 | Fierce Pharma
Teva warns on 2018 profit, may face migraine drug delays | ロイター
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva Finally Wins FDA Approval for Potential Huntington's Blockbuster Austedo | BioSpace
Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Teva eyes Asian expansion - Pharmaceutical Technology
Sex, drugs, and sharing trade secrets
EU fines drug makers for keeping cheap medicine off market
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva seeks blockbuster drug to succeed Copaxone - Globes
Teva to cut 14,000 jobs | Business | Chemistry World
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva stock downgraded to neutral by UBS on heels of $85 million opioid settlement - MarketWatch
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
Migraine treatment results in Japan boost Teva - Globes
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceuticals considers laying-off 10,000 workers - The Jerusalem Post
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
